POLATUZUMAB VEDOTIN-PIIQ | B761121 | GENENTECH
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Jun. 10, 2031 | Active | Computed |
| 7-Year Orphan | Apr. 19, 1930 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12371507(composition) · relevance 75/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 227 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.